Achieve Life Sciences (ACHV) Receivables (2010 - 2023)
Achieve Life Sciences (ACHV) posted Receivables of $111000.0 for Q4 2023, up 33.73% on a QoQ basis from $83000.0 in Q3 2023, and up 5.71% year-over-year from $105000.0 in Q4 2022.
Achieve Life Sciences (ACHV) Receivables (2010 - 2023) Analysis & Trends
Achieve Life Sciences' Receivables history runs 13 years deep, the most recent figure standing at $111000.0 for Q4 2023.
- Quarterly Receivables rose 5.71% year-over-year to $111000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $111000.0 (up 5.71% YoY) and the FY2023 annual result came in at $111000.0, up 5.71% from the prior year.
- Receivables was $111000.0 for Q4 2023 at Achieve Life Sciences, up from $83000.0 in the prior quarter.
- Across five years, Receivables topped out at $350000.0 in Q2 2023 and bottomed at $8000.0 in Q4 2019.
- A 4-year average of $150800.0 and a median of $128000.0 in 2022 frame the typical range for Receivables.
- Annual changes were most pronounced in 2019 — Receivables advanced 14.29% — and 2023, when it slumped 42.76%.
- Achieve Life Sciences' Receivables stood at $8000.0 in 2019, then surged by 1812.5% to $153000.0 in 2021, then plunged by 31.37% to $105000.0 in 2022, then gained by 5.71% to $111000.0 in 2023.
- Business Quant data shows ACHV's Receivables at $111000.0 in Q4 2023, $83000.0 in Q3 2023, and $350000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 4.97 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 938.02 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 1.13 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.00 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.73 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.93 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Achieve Life Sciences | 2.54 Mn | 2.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 111,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Jun 30, 2023 | 350,000.00 |
| Mar 31, 2023 | 89,000.00 |
| Dec 31, 2022 | 105,000.00 |
| Sep 30, 2022 | 145,000.00 |
| Jun 30, 2022 | 313,000.00 |
| Dec 31, 2021 | 153,000.00 |
| Sep 30, 2021 | 151,000.00 |
| Dec 31, 2019 | 8,000.00 |
| Dec 31, 2018 | 7,000.00 |
| Sep 30, 2018 | 25,000.00 |
| Jun 30, 2018 | 124,000.00 |
| Mar 31, 2018 | 7,000.00 |
| Dec 31, 2017 | 9,000.00 |
| Sep 30, 2017 | 70,000.00 |
| Jun 30, 2017 | 241,000.00 |
| Mar 31, 2017 | 237,000.00 |
| Dec 31, 2016 | 510,000.00 |
| Dec 31, 2015 | 125,000.00 |